Mevion Medical Systems, a leader in compact proton therapy solutions, has announced that its MEVION S250i Proton Therapy System has received approval from the National Medical Products Administration (NMPA) of China. This approval marks a significant milestone, making Mevion the…
Varian, a Siemens Healthineers company, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its RapidArc Dynamic solution. This innovative technology utilizes advanced algorithms to transform treatment planning, significantly reducing the time between consultation and treatment.…
GC Aesthetics® (GCA), a privately-held medical technology company specializing in aesthetic and reconstruction solutions, has announced the launch of an extensive, multi-center, prospective clinical study across Europe. This study aims to evaluate and confirm the safety, effectiveness, and patient satisfaction…
A new study published in Diabetic Medicine reveals that the standard NHS procedures for processing gestational diabetes blood sugar tests miss over 50% of cases. Gestational diabetes, if undiagnosed or untreated, can cause serious complications for both mother and baby,…
BiVACOR, a clinical-stage medical device company, has announced the successful completion of the first phase of its FDA Early Feasibility Study (EFS) for the BiVACOR Total Artificial Heart (TAH). Between July and November 2024, five patients received the BiVACOR TAH…
Cellular remote patient monitoring (RPM) from Smart Meter is a crucial tool for ensuring continuous, high-quality care, particularly during the busy holiday season. As the Centers for Disease Control and Prevention (CDC) reports, around 23% of patients with chronic conditions—roughly…
LivaNova PLC (Nasdaq: LIVN), a leading medical technology company, has announced the publication of two pivotal articles in Brain Stimulation journal detailing data from the unipolar cohort of its RECOVER clinical study. This research evaluates the safety and efficacy of…
Hologic, Inc. (Nasdaq: HOLX) announced today that it has signed an agreement with the Centers for Disease Control and Prevention (CDC) to develop analyte specific reagents (ASRs) — key components of laboratory-developed tests — to assist in detecting H5N1 bird…
Sensorion, a clinical-stage biotechnology company focused on hearing loss therapies, has announced promising safety data from its Phase 1/2 clinical trial, Audiogene, for SENS-501. This gene therapy targets congenital deafness caused by mutations in the OTOF (otoferlin) gene, which is…
CardioFocus, Inc., a medical device company focused on advancing ablation treatments for cardiac arrhythmias, has announced the successful treatment of the first group of patients using the investigational OptiShot™ Pulsed Field Ablation (PFA) System. This marks a significant milestone in…